From: Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review
Probiotic studies | Location | Inclusion criteria | Treatment used in study groups, n = | Treatment duration | Reported outcomes |
---|---|---|---|---|---|
Brunser 200638 | Santiago - Chile | 37 – 42 weeks gestation 3000 – 4200 g birth weight | 1) Probiotic: L Johnsonii La1 108 cfu/ g powder n=25 | 13 weeks | Average formula intake (ml/kg) |
 |  |  | 2) Prebiotic: FOS 2g n= 32/L |  | Fecal excretion of bifidobacteria, Lctobacillus, Enterobacteria (Log10(CFU)/g stool) |
 |  |  | 3) Breastfeeding n= 26 |  |  |
 |  |  | 4) In Placebo group: Conventional infant formula no probiotic or prebiotic n= 33 |  |  |
Chouraqui 200440 | France | Infants < 8 months | 1) Probiotic: B. lactis Strain Bb12 1.5 × 106 cfu/g powder, n=46 | 148 days | Diarrhea, stools/day, Spitting, regurgitation |
 |  |  | 2) In Placebo group: Conventional infant formula no probiotic or prebiotic, n=44 |  |  |
Gibson 200944 | Adelaide -Australia | > 37 weeks gestation, birth weight 2500–4500 g,<10 days old | 1) Probiotic group: Bifibacterium lactis. 3.85 × 108 cfu/g 100kcal, n= 72 | 7 months | Growth: Weight, length, head circumference |
 |  |  |  |  | Stool characteristics (data not shown) |
 |  |  | 2) Placebo group: Conventional infant formula no probiotic, n=70 |  | Stools, colic, spitting up, vomiting and restlessness |
 |  |  |  |  | Mean daily volume of formula intake |
 |  |  |  |  | GI infections, Respiratory infections |
Haschke-Becher 200845 | Santiago - Chile | 36 - 44 weeks gestation, birth weight > 2500 g at 16 weeks of age | 1) Probiotic group: Lactobacillus Johnsonii 1 × 108 cfu/g powder yielding 0.8 to 1.1 × 108 cfu/ 200 mls formula, n= 17 | 4 weeks | Growth: Weight, length, Formula intake |
Langhendries 199546 | Belgium, St Joseph-Montegnee-Rocourt | Healthy Full term infants | 1) Probiotic group: Bifibacterium Bifidum 106 cfu/g powder, n= 20 | 2 months | Bifidobacteria, Bacteriodes, Enterobacteria Log10 (CFU) / g of faeces |
2) Placebo group: conventional infant formula no probiotic, n= 20 | |||||
 |  |  | 3) Reference group: Human milk, n= 14 |  |  |
Petschow 200548 | Iowa, USA | Healthy full term infants, weight >2500g, appropriate for gestational age (0–3 months of age) | 1) Probiotic group: Lactobacillus GG 1 × 106 cfu/g powder yielding 108 cfu/day, n=15 | 7 day baseline, 14 days treatment period, 14 days follow up | Stool frequency, stool consistency |
2) Probiotic group: Lactobacillus GG 1 × 107 cfu/g powder yielding 109 cfu/day, n= 14 | |||||
3) Probiotic group: Lactobacillus GG 1 × 108 cfu/g powder yielding 1010 cfu/day, n= 15 | |||||
 |  |  | 4) Placebo group: Conventional infant formula no probiotic, n= 15 |  |  |
Urban 200850 | Johanesburg South Africa | 37 - 42 weeks gestation, 2500–4200 g birth weight, born to HIV+ mothers but infants tested HIV- | 1) Probiotic group Acidified formula and Bifidobacterium lactis n= 29 (cfu/g powder is not specified) | 4 months (119 days) | Growth: Males: Weight gain, length and head circumference |
Females: Weight gain, length and head circumference | |||||
2) No probiotic group: Acidified formula no probiotic, n= 28 | |||||
 |  |  | 3) Placebo group: Conventional infant formula, (whey adapted formula), n= 28 |  |  |
Weizman 200551 | Beer - Sheva Israel | > 38 weeks gestation, 4–10 months old | 1) Probiotic group: Bifidobacterium Lactis (BB-12) 1 × 107 cfu/g powder, n= 73 | 12 weeks | Episodes of diarrhea, |
Volume of feed / day | |||||
2) Probiotic group: Lactobacillus reuteri 1 × 107 cfu/g powder, n= 68 | Episodes of respiratory illness, antibiotic use, clinic visits | ||||
 |  |  | 3) Placebo group: Conventional infant formula no probiotic, n= 60 |  |  |
Weizman 200652 | Beer - Sheva Israel | > 38 weeks gestation, < 4 months (3–65 days of age) | 1) Probiotic group: Bifidobacterium Lactis (BB-12) 1 × 107 cfu/g powder yielding 2.2 × 108 cfu/180 mls reconstituted formula, n= 20 | 4 weeks | Growth: Weight, length, head circumference (final percentiles) |
 |  |  |  |  | Stooling effort score, stooling consistency score |
 |  |  | 2) Probiotic group: Lactobacillus reuteri 1 × 107 cfu/g powder yielding 2.2 × 108 cfu/180 mls reconstituted formula , n= 20 |  | Daily crying score and daily crying episodes |
 |  |  |  |  | Formula volume (mls/kg) |
 |  |  | 3) Placebo group: Conventional infant formula no probiotic, n=19 |  |  |
Ziegler 200355 | Iowa USA | ≥ 37 weeks gestation, Birth weight 2500g - 4500g (6–10 days of age) | 1) No probiotic group: Reduced Protein formula no probiotic or prebiotic n=40 | 112 days | Growth: Males: Weight, length, Females, weight, length |
2) Probiotic group: Reduced protein formula, Bifidobacterium lactis 3.6 × 107 cfu/g powder yielding 4.8 × 109 cfu/L reconstituted formula , n= 40 | Stool consistency | ||||
Crying, colic (data not shown) | |||||
Hospitalization, diarrhea, diarrhea (No. of episodes) | |||||
 |  |  | 3) Placebo group: Conventional infant formula, no probiotic, n=42 |  |  |